Trials / Completed
CompletedNCT03213743
Expression Profiling of microRNA Following Administration of Dexmedetomidine
Expression Profiling of microRNA Following Administration of Dexmedetomidine in Patients Undergoing Procedures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- First Affiliated Hospital of Kunming Medical University · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to find out the differential expression profiling of microRNA before and after adiministration of dexmedetomidine in patients undergoing procedures, and then investigators will do some in vitro studies to validate the functions of the microRNA.
Detailed description
Background and objective: The use of dexmedetomidine may have benefits on the clinical outcomes of cardiac surgery. MicroRNAs are non-coding RNA sequences that act as regulators of gene expression. Investigators conduct a study to determine the role of microRNAs in cardioprotection mediated by dexmedetomidine. Methods: In this study 3 patients were selected. The blood sample were taken before administration of dexmedetomidine.Investigators infused loading dose of dexmedetomidine for 10 minutes and maintaining dese of dexmedetomidine for 20 minutes.Thirty minutes after the administration, another blood samples were taken and stored in the liquid nitrogen and both the samples were marked. Those sample were analyzed for differentially expressed microRNA with Exiqon miRNA Array.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine Injection | Investigators gave the patients loading dose of dexmedetomidine for 10 minutes and maintaining dose of dexmedetomidine for 20 minutes. Investigators took blood samples before and after the administration of dexmedetomidine. |
Timeline
- Start date
- 2017-06-19
- Primary completion
- 2017-06-21
- Completion
- 2017-06-21
- First posted
- 2017-07-11
- Last updated
- 2017-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03213743. Inclusion in this directory is not an endorsement.